Mauna Kea Technologies SA

LSE:0P5I Stock Report

Market Cap: €24.0m

Mauna Kea Technologies Past Earnings Performance

Past criteria checks 0/6

Mauna Kea Technologies has been growing earnings at an average annual rate of 8%, while the Medical Equipment industry saw earnings declining at 5.9% annually. Revenues have been growing at an average rate of 3.7% per year.

Key information

8.0%

Earnings growth rate

19.6%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate3.7%
Return on equityn/a
Net Margin-18.8%
Next Earnings Update26 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Mauna Kea Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0P5I Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2312-2114
31 Mar 2310-7114
31 Dec 228-11114
30 Sep 228-12124
30 Jun 228-13144
31 Mar 228-13143
31 Dec 219-13143
30 Sep 218-13143
30 Jun 218-13133
31 Mar 218-13143
31 Dec 207-13143
30 Sep 207-13153
30 Jun 207-14153
31 Mar 208-15153
31 Dec 199-15163
30 Sep 199-15154
30 Jun 199-14144
31 Mar 199-13145
31 Dec 188-13135
30 Sep 188-12125
30 Jun 187-11114
31 Mar 188-11114
31 Dec 178-10114
30 Sep 178-10124
30 Jun 178-11124
31 Mar 179-10124
31 Dec 1610-10124
30 Sep 1610-10134
30 Jun 1610-10134
31 Mar 1610-11154
31 Dec 1510-13165
30 Sep 1511-13175
30 Jun 1512-14175
31 Mar 1512-14185
31 Dec 1412-14185
30 Sep 1412-13174
30 Jun 1411-12164
31 Mar 1411-12164
31 Dec 1311-12164
30 Sep 1311-12164
30 Jun 1311-13174

Quality Earnings: 0P5I is currently unprofitable.

Growing Profit Margin: 0P5I is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0P5I is unprofitable, but has reduced losses over the past 5 years at a rate of 8% per year.

Accelerating Growth: Unable to compare 0P5I's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0P5I is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.9%).


Return on Equity

High ROE: 0P5I's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.